| MK-4827 (tosylate) |
(3S)-3-[4-[7-(氨基羰基)-2H-吲唑-2-基]苯基]哌啶对甲苯磺酸盐 |
1038915-73-9 |
| Baricitinib |
巴瑞克替尼 |
1187594-09-7 |
| 2-(1-(ethylsulfonyl)azetidin-3-ylidene)acetonitrile |
2-[1-(乙基磺酰基)-3-氮杂环丁亚基]乙腈 |
1187595-85-2 |
| Capmatinib |
卡马替尼 |
1029712-80-8 |
| Trelagliptin succinate |
琥珀酸曲格列汀 |
1029877-94-8 |
| (S)-tert-butyl 3-(4-aMinophenyl)piperidine-1-carboxylate |
(3S)-3-(4-氨基苯基)-1-哌啶甲酸叔丁酯 |
1171197-20-8 |
| VX-661 |
VX-661 |
1152311-62-0 |
| (1R trans)-2-(3,4-difluorophenyl)cyclopropane amine |
(1R,2S)-REL-2-(3,4-二氟苯基)环丙胺盐酸盐 |
1156491-10-9 |
| (2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic acid |
(2R,4S)-5-(联苯-4-基)-4-[(叔丁氧基羰基)氨基]-2-甲基戊酸 |
1012341-50-2 |
| N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide |
N,4-二甲基-N-(4-硝基苯基)-1-哌嗪乙酰胺 |
1139453-98-7 |
| Cabozantinib Malate |
苹果酸卡博替尼 |
1140909-48-3 |
| Dacomitinib (PF299804) |
达克替尼 |
1110813-31-4 |
| 2,6-Difluoro-3-(propylsulfonaMido)benzoic acid |
唯罗菲妮中间体 |
1103234-56-5 |
| Tepotinib |
特泊替尼 |
1100598-32-0 |
| 6-Fluoro-1H-indole-4-carboxylic acid methyl ester |
6-氟-1H-吲唑-4-甲酸甲酯 |
1082040-43-4 |
| PARECOXIB SODIUM |
帕瑞昔布钠 |
198470-85-8 |
| Parecoxib |
帕瑞昔布 |
198470-84-7 |
| N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)isobutyraMide |
帕瑞昔布杂质 |
198470-82-5 |
| (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride |
(3R,4R)-N,4-二甲基-1-(苯基甲基)-3-哌啶胺盐酸盐 |
1062580-52-2 |
| Garenoxacin |
加雷沙星 |
194804-75-6 |
